Safety and efficacy of skimune tablet and gel with respect to psoriasis

---

Original Article

Author Details : Nimish Vador*, Bhavesh Vador

Volume : 6, Issue : 1, Year : 2020

Article Page : 1-4

https://doi.org/10.18231/j.ijced.2020.001

Suggest article by email

Get Permission

---

Abstract

Psoriasis is an autoimmune disorder. It is characterized by chronic inflammatory condition of skin. It
leads to thick, scaly plaques on skin . Current medication involves symptomatic treatment by the various
moisturizers, however, the effects do not last long and recurrence occurs. Based on several ancient text
a combination of herbs was formulated and named as Skimune tablet and Gel. Preclinical safety was
conducted which was found to be safe for the dose above 5000 mg/kg of body weight. The beneficial
effects of Skimune Tablet and Gel was clinically evaluated on patients with mild to moderate psoriasis. The
Dermatology Life Quality Index (DLQI) and Psoriasis area & severity index (PASI) score was evaluated to
understand the effects of tablet and Gel. Skimune tablet was found to be safe upto 5000mg/kg of body
weight in animals and was well tolerated in patients too. Skimune Tablet and Gel showed significant
improvement (P <0>

Keywords: Skimune, Psoriasis, Ayurveda, Inflammation, Chronic.

How to cite : Vador N , Vador B, Safety and efficacy of skimune tablet and gel with respect to psoriasis. IP Indian J Clin Exp Dermatol 2020;6(1):1-4

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.